Close

Add to pipeline

Save Close
You are viewing a limited version of this profile. To access i3's full capabilities.
Plant Health Care
Save
Company logo (jpg or png)
Parent company
Edit alternate names

Short description

Developer of agricultural biological products and technology solutions focused on improving crop performance

Founded in 1995
Founded in

Company type Private Public (PHC:LN)
Company type

Industry Group agriculture & food

Sector crop inputs

TRL Range 9
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters Raleigh, NC Raleigh, United States
Address
City
State
Zip
Country

Parent Companies

Website

Updated by Cleantech Group on 06/22/2021

Traction
  • 1 M&A items
tags
Similar companies
Customers
Save
Add Customer
Date Company
07/27/2011

INCOTEC INCOTEC

Plant Health Care and INCOTEC signed a non-exclusive, multi-year agreement to develop and market Plant Health Care’s Myconate in combination with INCOTEC’s proprietary seed treatment packages.

Confirmed by INCOTEC
Delete
Partnerships
Save
Add Partnership
Date Partner Type
04/25/2013
Arysta LifeScience Arysta LifeScience
Plant Health Care and Arysta LifeScience signed a Product Development and License Agreement. Arysta is to develop and commercialize crop products using Plant Health Care's proprietary Harpin alpha beta technology.
View source    
Confirmed by Arysta LifeScience
Licensor
Delete
Investment Rounds
Save

IPO INFORMATION

Date

07/06/2004

IPO status

Filed

IPO Type

IPO

Amount

$29.49M

Initial shares

Ticker symbol

PHC:LN

Exchange listed

AIM

Prospectus URL

Prospectus

Source URL

Source

Description

On admission, the company had 30,795,603 ordinary shares in issue and a market capitalization of approximately £16.01 million. The proceeds receivable by the company, after subtracting expenses, are estimated to be approximately £5.85 million.

Cancel Save
Add Investment
Date Investors Type Amount
11/20/2019 Ospraie Ag Science Ospraie Ag Science (1)
Post-money valuation of
This funding round was disclosed via regulatory filing
 Series A $3,025,887
Delete
Click to add IPO information
Products
Save
Add Product
Product image Name Product status Revenue model Cost metrics
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font